Keywords
Electroporation
electrolysis
electrochemical treatment
electrolytic electroporation
irreversible electroporation
© 2020 Elsevier B.V. All rights reserved.
E2 is the combination of reversible electroporation and electrolysis.
E2’s cell killing mechanism is ascribed to a synergistic effect of both components.
Cell death is initiated within the first two minutes after E2 application.
However, cell death occurs significantly delayed.
There is significant but innocuous temperature increase during E2 application.
Electrolytic Electroporation (E2) is the combination of reversible electroporation and electrolysis. It has been proposed as a novel treatment option to ablate tissue percutaneously. The present in vitro study in cells in suspension was performed to investigate the underlying mechanisms of action of E2. Different types of experiments were performed to isolate the effects of the electrolysis and the electroporation components of the treatment. Additionally, thermal simulations were performed to determine whether significant temperature increase contributes to the effect. The results indicate that E2’s cell killing efficacy is due to a combinational effect of electrolysis and reversible electroporation that takes place within the first two minutes after E2 application. The results further show that cell death after E2 treatment is significantly delayed. These observations suggest that cell death is induced in permeabilized cells due to the uptake of electrolysis species. Thermal simulations revealed a significant but innocuous temperature increase.
Electroporation
electrolysis
electrochemical treatment
electrolytic electroporation
irreversible electroporation
© 2020 Elsevier B.V. All rights reserved.
Update: Each purchase of Breathing+ will now include three machine washable mouthpieces. Previous buyers will be su… twitter.com/i/web/status/13328…
Update: We moved servers + relocated all our games to our servers, please be patient while google reviews all that… twitter.com/i/web/status/13237…
Registration and all functionalities at breathinglabs.com (and in our iOS and Android games) are fixed and fu… twitter.com/i/web/status/12407…
We are back in stock with Breathing+, currently searching for VR supplier, and setting up mass production for toys… twitter.com/i/web/status/11717…
BREAKING: Nintendo Co. Ltd (Japan) is implementing Breathing Games by @breathinglabs in FDA approved clinical trial… twitter.com/i/web/status/11580…
Notice to b2b partners: we are running late with some minor upgrade-> briefly running out of stock -> retail and b2… twitter.com/i/web/status/11337…
BREAKING: Our product BREATHING+ shows significant and reliable diagnostic value in comparison to standard spiromet… twitter.com/i/web/status/10812…
Video: Resperate company endorses pursed lip breathing and shows pulmonary function improvement in real time.… twitter.com/i/web/status/10711…
Notice on limited availability during July 25th and August 5th: Help and support will be mostly functional via supp… twitter.com/i/web/status/10148…
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.